The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia
But acquisition charges drag earnings into loss
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Highlights Mirvetuximab-based regimen promise
The acquisition aims to bolster Merck’s hematology portfolio with Terns’ lead oncology candidate, TERN-701
The decision is based on the phase 3 DESTINY-Breast11 trial
TERN-701, a next-generation therapy targeting chronic myeloid leukemia (CML), a form of blood cancer that still presents treatment challenges despite decades of advances
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
